Mechanism and prevention of neurotoxicity caused by β-amyloid peptides: Relation to Alzheimer's disease

Brain Research

Volumn 776, Issue 1-2, 1997, Pages 40-50

  Blanchard, Barbara J ^a   Konopka, Genevieve ^a   Russell, Margaret ^a   Ingram, Vernon M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Amyloid fibril; Amyloid peptide; Calcium homeostasis; Calcium ion channel; Calcium ion concentration; Decoy peptide; HNT neuron; Non NMDA channel

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMYLOID BETA PROTEIN; PROTEIN DERIVATIVE;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CHANNEL GATING; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN MODIFICATION; PROTEIN TARGETING;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; CALCIUM; CALCIUM CHANNELS; CELLS, CULTURED; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; ION CHANNEL GATING; LIGANDS; MAGNESIUM; MOLECULAR SEQUENCE DATA; NEUROFIBRILLARY TANGLES; NEURONS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031445940     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01003-2     Document Type: Article

References (21)

1. Arispe N., Pollard H.B., Rojas E. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc. Natl. Acad. Sci. USA. 90:1993;10573-10577.
2. Arispe N., Rojas E., Pollard H.B. Alzheimer disease amyloid β protein forms calcium channels in bilayer membranes: Blockade by tromethamine and aluminum. Proc. Natl. Acad. Sci. USA. 90:1993;567-571.
3. Barria A., Muller D., Derkach V., Griffith L.C., Scoderling T.R. Regulatory phosphorylation of AMPA-type glutamate receptors by CAM-KII during long-term potentiation. Science. 276:1997;2042-2045.
4. Chou P.Y., Fasman G.D. Prediction of the secondary structure of proteins from their amino acid sequence. Adv. Enzymol. Relat. Areas Mol. Biol. 47:1978;45-148.
5. Cotman C.W., Pike C.J., Copani A. Beta-amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging. 13:1992;587-590.
6. Durell S.R., Guy H.R., Arispe N., Rojas E., Pollard H.B. Theoretical models of the ion channel structure of amyloid β-protein. Biophys. J. 67:1994;2137-2145.
7. i in isolated rat melanotropes. Neuroendocrinology. 62:1995;111-122.
8. Han H., Weinreb P.H., Peter T., Lansbury J. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 2:1995;163-169.
9. B. Hille, Ionic Channels of Excitable Membranes, 2nd Edition, Sinauer Associates, 1992, ch. 6.
10. Kosik K.S. The Alzheimer's disease sphinx: a riddle with plaques and tangles. J. Cell. Biol. 127:1994;1501-1504.
11. Kowall N.W., Beal M.F., Busciglio J., Duffy L.K., Yankner B.A. An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P. Proc. Natl. Acad. Sci. USA. 88:1991;7247-7251.
12. Lam K.S., Salmon S.E., Hersh E.M., Hruby V.J., Kazmierski W.M., Knapp R.J. A new type of synthetic peptide library for identifying ligand-binding activity. Nature. 354:1991;82-84.
13. Lorenzo A., Yanker B.A. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA. 91:1994;12243-12247.
14. Pike C.J., Walencewicz A.J., Glabe C.G., Cotman C.W. In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
15. Pleasure S.J., Lee N.M. NTera 2 cells: A human cell line which displays characteristics of human committed neuronal progenitor cell. J. Neurosci. Res. 35:1993;585-602.
16. Sanderson K.L., Butler L., Ingram V.M. Aggregates of a β-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: relation to Alzheimer's disease. Brain Res. 744:1997;7-14.
17. Soto C., Kindy M.S., Baumann M., Frangione B. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Commun. 226:1996;672-680.
18. Tsien J.Z., Chen D.F., Gerber D., Tom C., Mercer E.H., Anderson D.J., Mayford M., Kandel E.R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 87:1996;1317-1326.
19. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
20. Yankner B.A., Duffy L.K., Kirschner D.A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-282.
21. Younkin D.P., Tang C.-M., Hardy M., Reddy U.R., Shi Q.-Y., Pleasure S.J., Lee V.M.Y., Pleasure D. Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc. Natl. Acad. Sci. USA. 90:1993;2174-2178.